Cancer and Lymphoma
Warnings on two Eczema Drugs
January 23rd, 2006
The FDA found two
common eczema drugs, Elidel Cream (pimecrolimus) and Protopic Ointment (tacrolimus),
have a possible risk for skin cancer and lymphoma. New warning labels
are being added to the boxes of these medications to warn patients.
There has not been
a concrete direct link for causing cancer; however there have been 78
cancer reports to the FDA with patients that have used these drugs. The
FDA’s Pediatric Drugs Advisory Committee wanted this warning put on
packaging a year ago. This was followed a month later with the FDA
issuing a Public Health Advisory letting physicians know of the possible
black-box warning says that the long-term safety of these drugs are
not determined at this time. It also says that these drugs should be a
second-line therapy for short-term treatment when other treatments have
not worked. The FDA said a second course of these drugs can be used
“after a period of time off treatment.”
of these drugs are conducting studies to insure that they are safe. The
drug manufacturers want to show that the claims are by the FDA are not warranted.
In the mean time both companies have complied with the FDA. There
needs to be research on whether it
causes cancer or not. Between the two drugs there have been
approximately 10 million people that have used these eczema treatments.
sometimes called dermatitis and it can affect all age groups. Children
will be affected around one-fifth of the time, when adults are affected
around one in twelve people. Skin can vary from a mild dry, hot and
itchy feeling, to a severe form when the skin becomes broken, raw, and
bleeding. Eczema is not contagious and treatment can reduce the
inflammation and discomfort associated with this disorder.
Best Syndication Staff Writer
common keywords and misspellings: eckzema dry skin
itchey dermitis ekzema